Arthneeti

Emami Q1 FY27 Share Price & Earnings Call Analysis

₹359.75-3.01% today
Market cap
₹15,709 Cr
P/E
20.74
ROE
26.17%
PEG
3.97
Price to sales
4.00
Debt to equity
0.06
52W high / low
₹546 / ₹360
Sales growth (5Y)
5.58%
EBITDA margin
24.82%
Net profit margin
19.45%
Promoter holding
54.84%
Sales (last year)
₹3,915 Cr

Emami is engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.(Source : 201903 Annual Report Page No: 193)

Guidance scorecard · Q1 FY27 call

What Emami Ltd's management guided
and where it ranks in Personal Products

#6of 7 in
Personal Products
Revenue10–20%MarginsFlatCapexPlannedFundraisingWhat management saidOrder bookWhat management said

RevenueQ1 FY27 call

10–20%
  • Domestic core business grew ~6% in Q1 FY27; hair care at 11%, skin care at 3% (Rajesh Sharma, pg 13).
  • Management expects better growth in core business for the remainder of the year (Rajesh Sharma, pg 13).
  • Strategic investments portfolio grew 61% and expected to sustain similar growth going forward (Dhruv Aggarwal, pg 5).
  • Start-ups like The Man Company, Brillare showing strong momentum with plans for new launches and expansion.
  • Kesh King expected to achieve double-digit growth by year-end after mid-single-digit growth in Q1 (Mohan Goenka, pg 11).
  • International business faced challenges but expected significant recovery and growth in Q3 and Q4.

2 more points from Emami Ltd's call on revenue

Create a free account to keep reading this call

Full Q1 FY27 analysis

MarginsQ1 FY27 call

Flat

See what Emami Ltd said on margins — free account, 30 seconds.

Full Q1 FY27 analysis

CapexQ1 FY27 call

Planned
  • Emami has made a significant strategic investment, including about INR 500 crores in Axiom, funded internally from surplus cash.
  • The company plans further investments in strategic start-ups and fast-growing segments, with a committed management focus on such acquisitions.
  • The strategic investment division, including four start-ups, is expected to grow aggressively, targeting INR 750-800 crores revenue by year-end.
  • Emami is actively scouting for incremental acquisition opportunities alongside consolidating recent ones.
  • They are enhancing supply chain planning, inventory management, and distribution visibility and implementing AI-driven sales code systems to improve operational efficiency.

2 more points from Emami Ltd's call on capex

Create a free account to keep reading this call

Full Q1 FY27 analysis

FundraisingQ1 FY27 call

See what Emami Ltd said on fundraising — free account, 30 seconds.

Full Q1 FY27 analysis

Order bookQ1 FY27 call

  • International business order execution faced challenges due to West Asia conflict and supply chain disruptions, especially for OTC pain management products.
  • The company is working to resolve regulatory approvals to move pain management products from India to Middle East markets.
  • Once resolved, management expects to regain momentum and see significant growth in international markets in Q3 and Q4 FY27.
  • The company remains optimistic about growth prospects due to diversified portfolio and ongoing strategic initiatives.
Full Q1 FY27 analysis
Full Personal Products ranking

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Personal Products
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Honasa Consumer LtdGood growth
    3
See all potential multibaggersWhere does Emami Ltd rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Personal Products companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹2,041 Cr61.0
240%+Flat₹400 Cr35.6
3Honasa Consumer Ltd20–40%Up 0–2%₹14,745 Cr58.4
410–20%Flat₹87,493 Cr42.1
510–20%Flat₹68,298 Cr34.4
6Emami LtdThis stock10–20%Flat₹16,419 Cr21.7

Sign up free to see every company in the sector ranking and track Emami Ltd.

Pro shows every company guiding 40%+ revenue growth →Full Personal Products ranking

Financials of Emami Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Emami Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +8368268659968919068911,0499639047991,152925
Expenses +636636632682682692645715744692622768739
Operating Profit199190233314209214246334219212177384186
OPM %24%23%27%32%24%24%28%32%23%23%22%33%20%
Other Income +148111111102215212221923
Interest1223322232333
Depreciation64464646484445464444454542
Profit before tax148150196276169178220301194187150345164
Tax %4%9%8%6%13%16%4%7%16%12%1%7%13%
Net Profit +142137180261147151211279162164148319143
EPS in Rs3.273.144.095.923.413.504.876.393.723.763.407.323.28

Financials of Emami Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +2,0762,3582,4882,5312,6952,6552,8813,1923,4063,5783,8093,780
Expenses +1,5361,6701,7291,8121,9701,9702,0002,2542,5502,6322,7962,820
Operating Profit5416887597197256858809388559461,014960
OPM %26%29%31%28%27%26%31%29%25%26%27%25%
Other Income +914431192546699069416875
Interest55458342121135710911
Depreciation34255309311325336367335247186178177
Profit before tax592423424393403374569688670791894846
Tax %18%14%20%22%25%19%20%-22%6%8%10%8%
Net Profit +485363340306303302455837627724803775
EPS in Rs10.708.007.506.776.686.6710.2319.0214.5016.5818.4817.76
Dividend Payout %33%44%47%52%60%60%78%42%55%48%54%34%

Financials of Emami Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital232323234545444444444444
Reserves1,2081,5891,7321,9912,0311,7781,7182,0322,2592,4032,6512,880
Borrowings +36671473326110210101282919490162
Other Liabilities +410409376458633644656692703728741751
Total Liabilities1,6762,6922,6032,7982,8192,6782,5203,0503,0963,2693,5253,836
Fixed Assets +4531,9181,9941,8021,6801,4591,1321,3441,2451,114984887
CWIP296722303686368151
Investments501104128314187156255303293442676834
Other Assets +6936044606529151,0551,1261,4001,5511,7061,8502,114
Total Assets1,6762,6922,6032,7982,8192,6782,5203,0503,0963,2693,5253,836

Financials of Emami Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +534562730588554531922644749779896801
Cash from Investing Activity +-237-1,313-306-276-26-231-224-234-122-210-345-181
Cash from Financing Activity +-215502-496-324-428-405-688-402-608-563-500-554
Net Cash Flow82-249-72-12100-106981965265
Free Cash Flow426430448465421383890164719750852770
CFO/OP116%96%105%93%89%89%115%84%101%98%107%101%

Financials of Emami Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days182014222942293744504333
Inventory Days596883878810211812110010294128
Days Payable9011285109115135138138124143133153
Cash Conversion Cycle-13-2412129101920948
Working Capital Days-16-54-62-32-67-3028302566
ROCE %61%30%23%22%19%18%29%31%28%32%32%30%

Guidance history

How Emami Ltd's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q1 FY27 call →10–20%FlatPlanned——
Q4 FY26 call →10–20%Up 0–2%Planned——
Q3 FY26 call →10–20%Flat———
Q2 FY26 call →10–20%Up 0–2%———

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

13out of 100

Momentum score · price trend

13 out of 100 — Cooling

Over the past year its share price has done worse than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months−33.7%19%
Last 6 months−19.1%23%
Last 3 months−9.6%46%

The price is 56.8% below its all-time high of ₹832.85 (6 Sept 2024). Stocks more than 20% below their peak have their score halved, so 26 became 13.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Emami Ltd: 0.4 × 19 + 0.4 × 23 + 0.2 × 46 = 26, halved to 13 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 30 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

What Emami Ltd's management said in earlier quarters

Others in Personal Products this season

  • Aakaar Medical (Q2 FY27)

    Revenue from operations in H1 FY27: INR 43.72 Cr, up 72.6% YoY from INR 25.32 Cr in H1 FY26 (Page 12, 11, 4) . Key investor presentation takeaways from Aakaar M

  • Recode Studios Ltd (Q4 FY26)

    The company plans to sustain marketing spends at about 20% of revenue to support growth and brand visibility, implying continued focus on operating profits…

  • Godrej Consumer Products Ltd (Q2 FY27)

    Consolidated net sales for Q2 FY2027: ₹4,396 crore, up 19% year-on-year; constant currency growth 15% (Page 8) . Key investor presentation takeaways from Godrej

  • Colgate-Palmolive (India) Ltd (Q2 FY27)

    1,692 crore, up 12.2% year-on-year from Rs. Key results statement takeaways from Colgate-Palmolive (India) Ltd's Q2 FY27 results statement — and how it ranks ag

Compare:vs Godrej Consumer Products Ltdvs Dabur India Ltdvs Cupid Ltd